Kontoor Brands acquires Helly Hansen for strategic growth despite a steep price. Read why I cautiously remain at a Hold ...

Discover the pros & cons of CWS: a tech-focused fund with premium valuation, mixed returns, & structural inefficiencies.

XDV:CA's performance lagged peers, offering only marginally higher yield but charging triple the expense ratio of comparable ...

Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

Looking closer at the portfolio, the 5-star ETF by Morningstar has high exposure to the value style. Just 11% of the ...

Recovery is likely delayed until 2027-2029, but Pernod Ricard's 5% dividend is safe. Click here to read why I rate PRNDY ...

Beauty continues to gain market share, expand internationally, and grow digital channels. Read why I will remain on the ...

Chipotle faces near-term headwinds, with weak revenue growth and declining operating cash flow overshadowing its long-term ...

Cidara Therapeutics' CD388 is aimed at providing universal protection with a single yearly dose for each flu season. See why ...

WEEK ETF offers weekly distributions from ultra-short T-Bills, catering to investors seeking regular income for everyday ...

Kronos' dividend cut and persistent negative free cash flow highlight ongoing financial strain. Read what justifies ...

IGR's 14.6% yield is eye-catching, but the fund's long-term total returns have been weak. Click here to find out why I view ...